Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
1,360 adverse event reports (+999% vs 2024)(first full year of widespread reporting)
In 2025, 1,360 adverse event reports were filed for Pneumococcal (Capvaxive) in VAERS. This represents 88.1% of all 1,543 reports for this vaccine.
Of these reports, 4 mentioned death, 42 involved hospitalization, 149 required ER visits, and 10 reported disability.
Compared to the average of 725 reports per year for this vaccine, 2025 was above average (+88%).
Year-over-year change: The large change from 2024 likely reflects a ramp-up in vaccination (e.g., new vaccine rollout or expanded eligibility) rather than a change in per-dose risk.
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2025 ← current | 1,360 | 4 | 42 |
| 2024 | 90 | 0 | 5 |
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.